Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hitting multiple targets with multimeric ligands.

Heather L Handl1, Josef Vagner, Haiyong Han

  • 1Arizona Cancer Center, Department of Biochemistry and Molecular Biophysics, 1515 N. Campbell Avenue, Tucson, AZ 85724-5024, USA.

Expert Opinion on Therapeutic Targets
|December 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimized Biomimetic Syntheses of Discorhabdin B and Aleutianamine Drives a Deeper Exploration of Their Anticancer Potential.

Journal of the American Chemical Society·2026
Same author

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced <i>KRAS</i>-Mutated Metastatic Pancreatic Cancer.

Journal of immunotherapy and precision oncology·2026
Same author

A Fluorescence Resonance Energy Transfer-Based Assay Targeting Tumor-Derived Extracellular Vesicles for Highly Specific Pancreatic Cancer Detection.

ACS nano·2025
Same author

Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.

Redox biology·2025
Same author

Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma.

British journal of cancer·2025
Same author

Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease.

Biomolecules·2025
Same journal

The biological role of CCR4 and its ligands CCL17 and CCL22 in atopic dermatitis: therapeutic implications and future directions.

Expert opinion on therapeutic targets·2026
Same journal

Hepatocyte nuclear factor 4α - prospects for therapeutic targeting.

Expert opinion on therapeutic targets·2026
Same journal

The role of bile acid receptors in cholestatic liver disease: pathophysiological insights and therapeutic advances.

Expert opinion on therapeutic targets·2026
Same journal

Molecular insights for targeting the Nrf1 pathway in hepatocellular carcinoma.

Expert opinion on therapeutic targets·2026
Same journal

Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy.

Expert opinion on therapeutic targets·2026
Same journal

The AT<sub>2</sub> receptor as a potential target for autosomal dominant polycystic kidney disease therapy?

Expert opinion on therapeutic targets·2026
See all related articles

Multimeric ligands, with multiple binding sites, offer enhanced affinity and selectivity for targeted therapies. Understanding their design, like linker flexibility and receptor density, is key to unlocking their full potential in drug discovery.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Multimeric ligands, composed of multiple monomeric units on a backbone, mimic natural binding mechanisms.
  • They exhibit higher affinity than monomers due to simultaneous receptor interactions.
  • Potential applications in targeted therapies exist, but design parameters require further investigation.

Purpose of the Study:

  • To review the binding mechanisms of multimeric ligands.
  • To identify knowledge gaps in multimeric ligand design.
  • To explore the potential of multimeric ligands in drug discovery.

Main Methods:

  • Examination of multimeric ligand binding in two distinct phases: prerecruitment and postrecruitment.
  • Discussion of factors influencing binding kinetics and thermodynamics.

Related Experiment Videos

  • Analysis of design characteristics like linker properties and receptor density.

    • Main Results:

    • The prerecruitment phase involves initial binding, increasing local ligand concentration and causing apparent cooperativity.
    • The postrecruitment phase, analogous to DNA interactions, relies on physical orientation for complex stability.
    • Various factors critically influence the overall binding process.

    Conclusions:

    • Multimeric ligands present a promising avenue for developing targeted therapies with enhanced affinity and selectivity.
    • Further research into quantitative design parameters is essential for optimizing multimeric ligand efficacy.
    • A comprehensive understanding of binding phases and influencing factors is crucial for their successful application.